Literature DB >> 29800730

The ADRA2A rs553668 variant is associated with type 2 diabetes and five variants were associated at nominal significance levels in a population-based case-control study from Mexico City.

Armando Totomoch-Serra1, María de Lourdes Muñoz2, Juan Burgueño3, María Cristina Revilla-Monsalve4, Ashael Perez-Muñoz1, Álvaro Diaz-Badillo5.   

Abstract

Type 2 diabetes (T2D) is a disease with a prevalence of 9.4% in Mexicans. Its etiology is complex involving environmental and genetic factors. The aim of this study was to analyse the association between PPARG rs1801282, PPARGC1A rs8192678, VEGFA rs2010963, ADRA2A rs553668, KCNQ1 rs2237892, SIRT1 rs7896005, IGF2BP2 rs4402960, and UCP3 rs3781907 single nucleotide variants (SNVs) with T2D and metabolic traits in a case-control study of a population from Mexico City. A total of 831 blood samples of non-diabetic, with healthy control participants (416) and individuals with T2D (415) were collected over a five-year period. After DNA extraction, genotyping was performed with TaqMan probes using real-time PCR. The genotypes were analysed for association with T2D in linear and logistic regressions adjusting for age, sex, and body mass index using the dominant, recessive, and additive models with a Bonferroni correction for multiple comparisons p < 0.001 and for association with related T2D traits fixed with a p < 2.3 × 10-4. The univariate analysis gives a significant (p < 1 × 10-4) for sex, triglycerides, and HOMA-IR. Significant association with T2D was found for ADRA2A rs553668 under the recessive model (OR = 3.640 and 95% CI of 2.330-5.690 (p < 1 × 10-4); statistical power 0.999) and under the additive model (OR = 1.640 and 95% CI of 1.340-2.000 (p < 1 × 10-4); statistical power 0.997). Variants PPARG rs1801282, PPARGC1A rs8192678, SIRT1 rs7896005, IGF2BP2 rs4402960 and UCP3 rs3781907 were nominally associated (p > 0.001 and <0.050). Results describe association of ADRA2A rs553668 with T2D in a Mexican population. Variants with nominal association with T2D require to be replicated in additional Mexican populations.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Case-control study; Mexico City; Single nucleotide variant; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29800730     DOI: 10.1016/j.gene.2018.05.078

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Data on a genome-wide association study of type 2 diabetes in a Maya population.

Authors:  Armando Totomoch-Serra; Miriam Givisay Domínguez-Cruz; María de Lourdes Muñoz; María Guadalupe García-Escalante; Juan Burgueño; Álvaro Díaz-Badillo; Nina Valadez-González; Doris Pinto Escalante
Journal:  Data Brief       Date:  2019-11-22

2.  Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients.

Authors:  Annika M A Berends; Mathieu S Bolhuis; Ilja M Nolte; Edward Buitenwerf; Thera P Links; Henri J L M Timmers; Richard A Feelders; Elisabeth M W Eekhoff; Eleonora P M Corssmit; Peter H Bisschop; Harm R Haak; Ron H N van Schaik; Samira El Bouazzaoui; Bob Wilffert; Michiel N Kerstens
Journal:  Biomedicines       Date:  2022-04-13

3.  Effect of KCNQ1 rs2237892 polymorphism on the predisposition to type 2 diabetes mellitus: An updated meta-analysis.

Authors:  Hong-Liang Jiang; Han Du; Ying-Jun Deng; Xue Liang
Journal:  Diabetol Metab Syndr       Date:  2021-07-08       Impact factor: 3.320

4.  Pleiotropic Effects of a KCNQ1 Variant on Lipid Profiles and Type 2 Diabetes: A Family-Based Study in China.

Authors:  Xiaowen Wang; Junhui Wu; Yao Wu; Mengying Wang; Zijing Wang; Tao Wu; Dafang Chen; Xun Tang; Xueying Qin; Yiqun Wu; Yonghua Hu
Journal:  J Diabetes Res       Date:  2020-01-13       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.